Literature DB >> 18266935

Involvement of dopamine receptors and beta-arrestin in metamphetamine-induced inclusions formation in PC12 cells.

Francesco Fornai1, Paola Lenzi, Loredana Capobianco, Luisa Iacovelli, Pamela Scarselli, Gloria Lazzeri, Antonio De Blasi.   

Abstract

Exposure of PC12 cells to metamphetamine (MA) induces the formation of multilamellar structures (whorls) resembling autophagic granules that subsequently develop as intracellular inclusions. These inclusions stain for a variety of antigens belonging to the ubiquitin proteasome pathway. Since MA-induced intracellular bodies require the presence of dopamine in the present study we analyzed the role of dopamine (DA) receptors in producing neuronal inclusions. Moreover, we investigated potential signaling pathways which could lead to ubiquitination in the presence of MA. Based on recent reports that ubiquitination of beta-adrenergic receptors is promoted by beta-arrestin which shuttles proteins from the plasma membrane to the ubiquitin proteasome system we investigated whether beta-arrestin is involved in MA-induced inclusion formation. Our experiments document that (i) beta-arrestin was associated with MA-induced intracellular bodies; (ii) MA induced a rapid and reversible ubiquitination of beta-arrestin; (iii) dopamine antagonists reduced both MA-induced beta-arrestin ubiquitination and intracellular whorls formation; (iv) the number of MA-induced intracellular bodies was reduced in cells transfected with the beta-arrestin dominant negative mutant, betaarrV53D and was increased by the persistently ubiquitinated beta-arrestin-ubiquitin fusion protein. In conclusion, the present study demonstrates the involvement of beta-arrestin in MA-induced intracellular bodies and the participation of dopamine receptors in this process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266935     DOI: 10.1111/j.1471-4159.2008.05284.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Acute ethanol exposure reduces serotonin receptor 1A internalization by increasing ubiquitination and degradation of β-arrestin2.

Authors:  Deborah J Luessen; Haiguo Sun; Molly M McGinnis; Michael Hagstrom; Glen Marrs; Brian A McCool; Rong Chen
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

2.  Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells.

Authors:  M Lin; P Chandramani-Shivalingappa; H Jin; A Ghosh; V Anantharam; S Ali; A G Kanthasamy; A Kanthasamy
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

Review 3.  Methamphetamine toxicity and messengers of death.

Authors:  Irina N Krasnova; Jean Lud Cadet
Journal:  Brain Res Rev       Date:  2009-03-25

4.  Expression and Role of the BDNF Receptor-TrkB in Rat Adrenal Gland under Acute Immobilization Stress.

Authors:  Yusuke Kondo; Juri Saruta; Masahiro To; Naoto Shiiki; Chikatoshi Sato; Keiichi Tsukinoki
Journal:  Acta Histochem Cytochem       Date:  2010-12-03       Impact factor: 1.938

Review 5.  Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology.

Authors:  Shaobin Yu; Ling Zhu; Qiang Shen; Xue Bai; Xuhui Di
Journal:  Behav Neurol       Date:  2015-03-12       Impact factor: 3.342

Review 6.  Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease.

Authors:  Stefano Gambardella; Francesca Biagioni; Rosangela Ferese; Carla L Busceti; Alessandro Frati; Giuseppe Novelli; Stefano Ruggieri; Francesco Fornai
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

Review 7.  Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress.

Authors:  Fiona Limanaqi; Stefano Gambardella; Francesca Biagioni; Carla L Busceti; Francesco Fornai
Journal:  Oxid Med Cell Longev       Date:  2018-07-22       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.